The ABILITY Diabetes Global study has now been officially published in The Lancet, marking an important milestone for this large international clinical trial.
The study was conducted under the scientific leadership of Mount Sinai and sponsored by Concept Medical, with the active involvement of a global network of investigators. Several members of the CERC scientific board played a key role in the study, contributing their expertise throughout the trial and to the resulting publication.
As a cardiovascular-focused CRO, CERC is proud to have supported this study through rigorous trial management, scientific coordination, and close collaboration with investigators and partners worldwide.
This publication further demonstrates the strength of CERC’s scientific governance and its commitment to advancing evidence-based cardiovascular research in high-risk patient populations.
Read the full publication
CERC. Smart trials. Strong results.
